Adenoma

Explore clinical trials studying Adenoma. Study availability and eligibility vary by location and protocol.

597 public trials 137 recruiting studies

Refine in advanced search Browse all conditions

Adenoma trial results

Active, Not Recruiting

Trial of ERapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance

NCT04230499

Conditions: Adenoma, Adenomatous Polyposis Coli, Adenomatous Polyps, +17 more
Locations: Michigan Medicine Ann Arbor, Michigan, United States

Cleveland Clinic Cleveland, Ohio, United States

Ohio State University Columbus, Ohio, United States

UT Health San Antonio, Texas, United States

View Trial Details

Active, Not Recruiting

Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients

NCT04287829

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: Antoni van Leeuwenhoekziekenhuis (NKI-AVL) Amsterdam, North Holland, Netherlands

View Trial Details

Active, Not Recruiting

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

NCT05215574

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +83 more
Locations: NGM Clinical Study Site Gilbert, Arizona, United States

NGM Clinical Study Site Los Angeles, California, United States

NGM Clinical Study Site Sarasota, Florida, United States

NGM Clinical Study Site Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies

NCT03546426

Conditions: Adenoma, Advanced Cancer, Disease Attributes, +18 more
Locations: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Meldola, FC, Italy

View Trial Details

Active, Not Recruiting

Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma

NCT04300244

Conditions: Adenoma, Cancer, Cancer of Lung, +17 more
Locations: University of Western Australia Perth, Australia

Aalborg University Hospital Aalborg, Denmark

Copenhagen University Hospital Copenhagen, Denmark

Oslo University Hospital Oslo, Norway

View Trial Details

Active, Not Recruiting

Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma

NCT03022188

Conditions: Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +13 more
Locations: Clinique Universitaire Saint Luc Leuven, Belgium

Hopital Sud Amiens, France

CHU Angers Angers, France

CHRU Jean Minjoz Besançon, France

View all 22 locations

View Trial Details

Active, Not Recruiting

Feasibility of Molecular Biology in Pancreatic Cyst Tumors

NCT03305146

Conditions: Adenoma, Cystadenoma, Cystadenoma, Mucinous, +13 more
Locations: Clinique de Bercy Charenton-le-Pont, France

Centre Hospitalier Universitaire Dupuytren Limoges, France

Hopital Edouard Herriot Lyon, France

Hopital Mermoz Lyon, France

View Trial Details

Adenoma

Adenoma trial results

Trial of ERapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance

Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies

Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma

Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma

Feasibility of Molecular Biology in Pancreatic Cyst Tumors

Related conditions